Eagle Pharmaceuticals (EGRX) Stock Chart & Stock Price History $3.00 +0.11 (+3.63%) As of 09:30 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Eagle Pharmaceuticals Stock Price Performance The Eagle Pharmaceuticals (EGRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 45.45%, with a year-to-date return of 500.00%. In the past month, the stock has increased 51.90%, reflecting recent market activity. As of the latest close, Eagle Pharmaceuticals traded at $2.90 with a market cap of $37.60 million and volume of 717 shares. Five years ago, the stock traded at $48.46, representing a 93.81% decrease over that period. At the time, it had a market cap of $656.61 million and a volume of 285,725 shares. Receive EGRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.45%1 Month Performance+51.90%3 Month Performance+100.00%Year-To-Date Performance+500.00%1 Year Performance-45.45%5 Year Performance-93.81% EGRX Stock Chart for Thursday, July, 3, 2025 EGRX Chart by TradingView Eagle Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/02/2025$2.36$2.90+22.67%$3.00$2.40717 shs$37.60 million07/01/2025$2.90$2.36-18.62%$2.90$2.35823 shs$30.65 million06/30/2025$2.90$2.90$2.95$2.307,821 shs$37.66 million06/27/2025$2.70$2.90+7.41%$2.95$2.307,821 shs$37.66 million06/26/2025$2.70$2.70$2.70$2.301,123 shs$35.07 million06/25/2025$2.75$2.70-1.82%$2.70$2.301,123 shs$35.07 million06/24/2025$2.79$2.75-1.43%$2.75$2.201,546 shs$35.71 million06/23/2025$2.88$2.79-2.96%$2.88$2.102,812 shs$36.23 million06/20/2025$2.35$2.88+22.34%$2.88$2.35742 shs$37.34 million06/19/2025$2.35$2.35$2.35$2.35110 shs$30.52 million Get the Latest News and Ratings for EGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/18/2025$2.35$2.35$2.35$2.352 shs$30.52 million06/17/2025$2.35$2.35$2.44$2.009,426 shs$30.52 million06/16/2025$2.40$2.35-2.08%$2.44$2.009,426 shs$30.52 million06/13/2025$2.35$2.40+2.13%$2.50$2.2021,871 shs$31.17 million06/12/2025$2.30$2.35+2.17%$2.35$2.1913,270 shs$30.52 million06/11/2025$2.10$2.30+9.52%$2.30$2.00592 shs$29.87 million06/10/2025$2.25$2.10-6.67%$2.10$2.10101 shs$27.27 million06/09/2025$2.25$2.25$2.25$2.006,690 shs$29.22 million06/06/2025$2.20$2.25+2.27%$2.25$2.006,690 shs$29.22 million06/05/2025$2.10$2.20+4.76%$2.25$2.006,244 shs$28.57 million06/04/2025$1.98$2.10+6.33%$2.30$1.9032,628 shs$27.27 million06/03/2025$2.00$1.98-1.25%$1.98$1.50507 shs$25.65 million06/02/2025$1.90$2.00+5.26%$2.00$1.65304 shs$25.97 million Related Companies FATE Stock Price Chart KYTX Stock Price Chart BDTX Stock Price Chart VXRT Stock Price Chart LXEO Stock Price Chart LYEL Stock Price Chart BYSI Stock Price Chart NMRA Stock Price Chart NKTX Stock Price Chart FTLF Stock Price Chart Receive EGRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EGRX) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eagle Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eagle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
